{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:31:19Z","timestamp":1792276279368,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jns.2019.01.018","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T11:21:53Z","timestamp":1547637713000},"page":"196-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database"],"prefix":"10.1016","volume":"398","author":[{"given":"C.","family":"Lacroix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kheloufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Bennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pizzoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.01.018_bb0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yebeh.2015.04.034","article-title":"Drug-induced status epilepticus","volume":"49","author":"Cock","year":"2015","journal-title":"Epilepsy Behav. EB."},{"key":"10.1016\/j.jns.2019.01.018_bb0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.01.018_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2019.01.018_bb0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/omcr\/omw042","article-title":"Cefepime-induced encephalopathy with normal renal function","volume":"2016","author":"Meillier","year":"2016","journal-title":"Oxf. Med. Case Rep."},{"key":"10.1016\/j.jns.2019.01.018_bb0025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.yebeh.2005.09.010","article-title":"Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function","volume":"8","author":"Maganti","year":"2006","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2019.01.018_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)00767-7","article-title":"Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure","volume":"111","author":"Mart\u00ednez-Rodr\u00edguez","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2019.01.018_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ebcr.2016.04.005","article-title":"Nonconvulsive status epilepticus cases arising in connection with cephalosporins","volume":"6","author":"Bora","year":"2016","journal-title":"Epilepsy Behav. Case Rep."},{"key":"10.1016\/j.jns.2019.01.018_bb0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne","year":"2017","journal-title":"Crit. Care Lond. Engl."},{"key":"10.1016\/j.jns.2019.01.018_bb0045","author":"Research C for DE and"},{"key":"10.1016\/j.jns.2019.01.018_bb0050","first-page":"72","article-title":"Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection","volume":"67","author":"Roncon-Albuquerque","year":"2009","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.jns.2019.01.018_bb0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10072-011-0668-3","article-title":"Cefixime-induced nonconvulsive status epilepticus","volume":"33","author":"Anzellotti","year":"2012","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2019.01.018_bb0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clineuro.2008.06.007","article-title":"Epidural adhesiolysis complicated by cefazolin-induced status epilepticus: two cases","volume":"110","author":"Choi","year":"2008","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2019.01.018_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.55.4.333","article-title":"Ceftazidime encephalopathy: absence status and toxic hallucinations","volume":"55","author":"Jackson","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.01.018_bb0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.47102\/annals-acadmedsg.V36N6p450","article-title":"Cefepime-induced encephalopathy with triphasic waves in three Asian patients","volume":"36","author":"De Silva","year":"2007","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.jns.2019.01.018_bb0075","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1528-1167.2005.16305.x","article-title":"Cephalosporin-induced nonconvulsive status epilepticus: clinical and electroencephalographic features","volume":"46","author":"Fern\u00e1ndez-Torre","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2019.01.018_bb0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1590\/0004-282X20140094","article-title":"Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPDs) associated with seizures in cefepime neurotoxicity","volume":"72","author":"Passarelli","year":"2014","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jns.2019.01.018_bb0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10072-010-0425-z","article-title":"Reversible encephalopathy induced by cefoperazone: a case report monitored with EEG","volume":"32","author":"Pro","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2019.01.018_bb0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.therap.2016.02.028","article-title":"Pharmacovigilance fran\u00e7aise: missions, organisation et perspectives","volume":"71","author":"Vial","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.jns.2019.01.018_bb0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jpsychires.2017.02.008","article-title":"Drug-induced panic attacks: Analysis of cases registered in the French Pharmacovigilance Database","volume":"90","author":"Abadie","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2019.01.018_bb0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2515\/therapie\/2015026","article-title":"Drug-induced depression: a case\/non case study in the French Pharmacovigilance Database","volume":"70","author":"Lafay-Chebassier","year":"2015","journal-title":"Therapie"},{"key":"10.1016\/j.jns.2019.01.018_bb0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neucli.2006.12.003","article-title":"Drug-induced myoclonus: a French Pharmacovigilance Database study","volume":"36","author":"Brefel-Courbon","year":"2006","journal-title":"Neurophysiol. Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2019.01.018_bb0110","unstructured":"International conference of harmonisation of technical requirements for registration of pharmaceuticals for human use. Post-approval safety data management: definitions and standards for expedited reporting E2D. 2003."},{"key":"10.1016\/j.jns.2019.01.018_bb0115","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.01595-08","article-title":"High Cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function","volume":"54","author":"Lamoth","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jns.2019.01.018_bb0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1128\/AAC.00389-08","article-title":"Continuous Cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations","volume":"53","author":"Zeller","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jns.2019.01.018_bb0125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jac\/dkn522","article-title":"Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis","volume":"63","author":"Seguin","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jns.2019.01.018_bb0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/FTD.0b013e3181e60ca6","article-title":"Prospective determination of serum ceftazidime concentrations in intensive care units","volume":"32","author":"Aubert","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jns.2019.01.018_bb0135","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.clinthera.2014.09.020","article-title":"Neurotoxicity with antimicrobials in the elderly: a review","volume":"36","author":"Mattappalil","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jns.2019.01.018_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jfma.2013.05.002","article-title":"Cefepime-induced nonconvulsive status epilepticus as a cause of confusion in an elderly patient","volume":"114","author":"Chang","year":"2015","journal-title":"J. Formos. Med. Assoc. Taiwan Yi Zhi."},{"key":"10.1016\/j.jns.2019.01.018_bb0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.pediatrneurol.2012.08.017","article-title":"Pediatric Cefepime neurotoxicity","volume":"47","author":"Landgrave","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jns.2019.01.018_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcma.2011.01.017","article-title":"Cefepime-related encephalopathy in peritoneal dialysis patients","volume":"74","author":"Lin","year":"2011","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.jns.2019.01.018_bb0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2003.09.003","article-title":"Cefepime-induced encephalopathy","volume":"8","author":"Dakdouki","year":"2004","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jns.2019.01.018_bb0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00467-003-1333-8","article-title":"Cefepime-induced non-convulsive status epilepticus in a peritoneal dialysis patient","volume":"19","author":"Alpay","year":"2004","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jns.2019.01.018_bb0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.bmt.1704314","article-title":"Nonconvulsive status epilepticus associated with cefepime in a patient undergoing autologous stem cell transplantation","volume":"33","author":"Plensa","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jns.2019.01.018_bb0170","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40264-017-0578-2","article-title":"Neurological adverse effects attributable to \u03b2-Lactam antibiotics: a literature review","volume":"40","author":"Deshayes","year":"2017","journal-title":"Drug Saf."},{"key":"10.1016\/j.jns.2019.01.018_bb0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.23.3.369.32100","article-title":"Retrospective review of neurotoxicity induced by cefepime and ceftazidime","volume":"23","author":"Chow","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jns.2019.01.018_bb0180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0140-6736(92)91476-O","volume":"340","author":"Penicillin, ceftazidime, and the epilepsies","year":"1992","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jns.2019.01.018_bb0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0253-7613.91884","article-title":"Ceftriaxone-induced acute reversible encephalopathy in a patient with enteric fever","volume":"44","author":"Sharma","year":"2012","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.jns.2019.01.018_bb0190","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/postgradmedj-2017-134999","article-title":"Iatrogenic coma: ceftriaxone-associated encephalopathy","volume":"94","author":"Dubin","year":"2018","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.jns.2019.01.018_bb0195","first-page":"1","article-title":"Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient","volume":"2014","author":"Safadi","year":"2014","journal-title":"Case Rep. Nephrol."},{"key":"10.1016\/j.jns.2019.01.018_bb0200","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3346\/jkms.2012.27.9.1120","article-title":"Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review","volume":"27","author":"Kim","year":"2012","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jns.2019.01.018_bb0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2011.12.029","article-title":"The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice","volume":"509","author":"Chen","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2019.01.018_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2009.07.018","article-title":"Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking","volume":"67","author":"Knackstedt","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jns.2019.01.018_bb0215","doi-asserted-by":"crossref","first-page":"9239","DOI":"10.1523\/JNEUROSCI.1746-09.2009","article-title":"Upregulation of Glt1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats","volume":"29","author":"Sari","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2019.01.018_bb0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/alcalc\/agr023","article-title":"Ceftriaxone, a Beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats","volume":"46","author":"Sari","year":"2011","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.jns.2019.01.018_bb0225","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jns.2019.01.018_bb0230","author":"C\u00e9f\u00e9pime: rappel des risques de r\u00e9actions graves lors du non respect des posologies recommand\u00e9es notamment en cas de d'insuffisance r\u00e9nale - Point d'Information - ANSM: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 [Internet]"},{"key":"10.1016\/j.jns.2019.01.018_bb0235","author":"C\u00e9f\u00e9pime (Axepim\u00ae et ses g\u00e9n\u00e9riques): rappel des risques d'effets ind\u00e9sirables neurologiques graves lors du non-respect des posologies recommand\u00e9es notamment en cas d'insuffisance r\u00e9nale - Lettre aux professionnels de sant\u00e9 - ANSM: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 [Internet]"},{"key":"10.1016\/j.jns.2019.01.018_bb0240","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.revmed.2006.02.003","article-title":"Effets ind\u00e9sirables psychiatriques des fluoroquinolones: cas notifi\u00e9s \u00e0 la pharmacovigilance fran\u00e7aise","volume":"27","author":"Doussau de Bazignan","year":"2006","journal-title":"Rev. M\u00e9d. Interne."},{"key":"10.1016\/j.jns.2019.01.018_bb0245","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cmi.2017.01.005","article-title":"Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study","volume":"23","author":"Huwyler","year":"2017","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19300188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19300188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:47:08Z","timestamp":1758383228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19300188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":49,"alternative-id":["S0022510X19300188"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.01.018","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}